The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is:

• Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors?

Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.

Inclusion Criteria:

• Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
• Admitted to the hospital ≥ 24 hours
• Discharged from the hospital alive
• San Francisco resident or unhoused in San Francisco
• Capacity for informed consent

Exclusion Criteria:

• Patient < 18 years old
• Deceased during index hospitalization
• Unable to provide informed consent

The investigators are undecided how individual participant data will be shared with other researchers, which the investigators will update prior to the initial recruitment date. The primary outcome will be qualitative data from in-depth semi-structured interviews linked to participant demographic and clinical information. The secondary outcome will be quantitative based on resource utilization, also linked to participant demographic and clinical information.